Corvus Pharmaceuticals (CRVS) Soars 212% on Impressive Eczema Therapy Study

Jan 27, 2026 - 09:00

0

Corvus Pharmaceuticals (CRVS) Soars 212% on Impressive Eczema Therapy Study

Related Posts

DOGE says IRS modernization program is $15B over budget and 30 years overdue

DOGE says IRS modernization program is $15B over budget...

Mar 21, 2025 2

Disney investor pledges to continue fight as shareholders reject proposal to distance company from LGBT group

Disney investor pledges to continue fight as shareholde...

Mar 21, 2025 3

London's Heathrow Airport to reopen after fire causes power outage

London's Heathrow Airport to reopen after fire causes p...

Mar 21, 2025 7

Atea Pharmaceuticals Issues Statement Regarding Director Nominations

Atea Pharmaceuticals Issues Statement Regarding Directo...

Mar 21, 2025 3

JPMorgan rebrands diversity program

JPMorgan rebrands diversity program

Mar 21, 2025 7

Dream Finders Homes director Lovett sells $2.65 million in stock

Dream Finders Homes director Lovett sells $2.65 million...

Mar 21, 2025 0